Press Releases Keyword Search Items Per Page 102550 Year None202120202019201820172016201520142013 Recent News July 1, 2021 Seres Therapeutics, Nestlé Health Science Announce SER-109 Co-Commercialization License Agreement June 8, 2021 Aimmune Launches the First Real-World Registry Study for Patients with Chronic Pancreatitis February 25, 2021 Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years
July 1, 2021 Seres Therapeutics, Nestlé Health Science Announce SER-109 Co-Commercialization License Agreement
June 8, 2021 Aimmune Launches the First Real-World Registry Study for Patients with Chronic Pancreatitis
February 25, 2021 Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years
